Total Reports
20
Below-median volume
Horse /
Breed profile · FDA CVM July 2026 extract
Icelandic Pony adverse-event record
Adverse-event filings for Icelandic Pony (Horse) in the FDA Center for Veterinary Medicine openFDA extract. Browse horse breeds, reactions, and outcomes below.
- #362 of 510
- by report volume (all breeds)
- 20
- FDA CVM reports on file
- 10.0%
- death-coded share of reports
- 3
- Ataxia - top reaction
How the 20 reports break down
By recorded gender -- every report on file for Icelandic Pony, no filtering.
Annual report volume
Data updated September 2026
The verdict
According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Icelandic Pony ranks #362 of 510 by total reports (20). Death-coded-share rank requires at least 50 reports. National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).
- 93,675
- Retriever - Labrador reports (#1)
- 99.0%
- Atlantic Salmon (Salmo salar) death share (#1)
- #362
- This breed, reports of 510
Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.
Release-over-release change
What changed in the latest FDA data snapshot
PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Icelandic Pony has 20 reports now versus 17 in that prior snapshot: 3 more (17.6%).
- Report change
- +3
- Death-coded reports
- +0
- Death-coded share
- −1.8 pts
This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.
Subscribe to Icelandic Pony changesDeaths Reported
2
of 20 reports
Death-coded share of reports
10.0%
10.0% death-coded
Avg Age at Report
14.2 yr
318.9 kg avg weight
Death-Coded Outcome Share
Icelandic Pony death-coded reports 10.0%
Cross-breed median
10.0% of 20 icelandic pony reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 318.9 kg (703.2 lbs)
Top Reported Reactions
Ataxia 3
Injection site swelling 2
Elevated liver enzymes 2
Laminitis 2
INEFFECTIVE, GASTRIC ULCER(S) 2
Most Referenced Drugs
Pergolide Mesylate 8
Omeprazole 6
Ceftiofur Crystalline Free Acid 2
Misoprostol 2
Firocoxib 1
Outcome Breakdown
Outcome Unknown
7 (43.8%)
Ongoing
5 (31.3%)
Recovered/Normal
2 (12.5%)
Died
1 (6.3%)
Euthanized
1 (6.3%)
Gender Distribution
Female 10 (50.0%)
Male 8 (40.0%)
Mixed 1 (5.0%)
Unknown 1 (5.0%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2011 | 2 | |
| 2012 | 3 | |
| 2014 | 1 | |
| 2015 | 2 | |
| 2016 | 1 | |
| 2018 | 2 | |
| 2019 | 2 | |
| 2020 | 1 | |
| 2022 | 1 | |
| 2023 | 2 | |
| 2025 | 1 | |
| 2026 | 2 | |
Icelandic Pony: high death-coded share in the FDA CVM extract
Signature read: 20 reports place Icelandic Pony in the lower third of breed filing volume (#362 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Icelandic Pony sits at #362 of 510 by report volume among all breeds and #38 of 55 among horse breeds, with 20 reports and 2 (10.0%) death-coded. Mean age at report: 14.2 years, average weight 318.9 kg (703.2 lbs).
Top reported signs: Ataxia (3), Injection site swelling (2), Elevated liver enzymes (2). Most-referenced drug: Pergolide Mesylate (8 reports), followed by Omeprazole (6) and Ceftiofur Crystalline Free Acid (2).
Outcome coding on 16 status-recorded reports is dominated by Outcome Unknown (43.8%). Annual submissions ranged 1-2,026 across 12 years on file.
Horse Breeds With a Similar Report Volume
Showing 6 of 54 horse breeds in our dataset, ranked by closest report volume.
Nationwide breeds with similar profiles
Sparse-volume peer sets for Icelandic Pony drawn from openFDA outside the Horse family so the neighborhoods are not species containment (the similar-volume list above stays within species).
Similar average weight
Nearest other-species breeds by reported average weight (318.9 kg here).
What to do with this horse
- Compare Icelandic Pony's report volume and death-coded share against similar-volume breeds nationwide. See similar breeds
- Read how death-coded share differs from a mortality rate before drawing conclusions. Breed-specific risks guide
- Browse every horse breed we track for comparison. All horse breeds
A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.
Frequently Asked Questions
How many FDA adverse event reports involve Icelandic Pony? ▼
There are 20 adverse event reports involving Icelandic Pony in the FDA database, of which 2 were death-coded (10.0% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Icelandic Pony ranks #362 of 510 by report volume among all breeds PlainBreed indexes (#38 of 55 among horse breeds).
Where does Icelandic Pony sit among other breeds in PlainBreed's corpus? ▼
According to FDA CVM report volume, Icelandic Pony is #362 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Horse, it is #38 of 55. It has fewer than 50 reports, so it is outside the death-rate ranking cohort (≥50 reports). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Icelandic Pony? ▼
The most commonly reported adverse reactions for Icelandic Pony are Ataxia (3 reports), Injection site swelling (2 reports), Elevated liver enzymes (2 reports), Laminitis (2 reports), INEFFECTIVE, GASTRIC ULCER(S) (2 reports).
What drugs are most frequently associated with Icelandic Pony adverse events? ▼
The drugs most frequently referenced in Icelandic Pony adverse event reports are Pergolide Mesylate (8 reports), Omeprazole (6 reports), Ceftiofur Crystalline Free Acid (2 reports), Misoprostol (2 reports), Firocoxib (1 reports).
What is the average age of Icelandic Pony in adverse event reports? ▼
The average age of Icelandic Pony at the time of adverse event reports is 14.2 years, with an average weight of 318.9 kg (703.2 lbs).
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.
Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025
openFDA Animal & Veterinary Adverse Events (FDA CVM) for Icelandic Pony (Horse), extract as of July 2026 extract. 20 reports · 2 death-coded (10.0% of reports, not a mortality rate) · #362 of 510 by volume.
Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →